PTC Therapeutics, Inc.

About PTC Therapeutics, Inc.

PTC Therapeutics is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for children and adults with serious diseases of high unmet need. Their mission is to deliver transformative therapies and drive investment in a diversified pipeline to address rare diseases.

Products & Services

Approved Therapies:Includes groundbreaking treatments such as the first approved treatment for Duchenne muscular dystrophy, the first gene therapy infused directly into the brain, and the first small molecule splicing modifier.

Pipeline Products:A diverse pipeline targeting conditions with significant unmet medical needs.

Specialties

Rare Disease Treatments Splicing Modulation Inflammation & Ferroptosis Gene Therapy Neurology Metabolic Disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Notes T: - FT: Convertible Notes	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2026-06-15 FD: 2026-06-15	1 investors
2	RT: Asset Sale T: - FT: Asset Sale	A: 150000000 MR: - FA: 150 million FAN: 150000000	D: 2024-11-27 FD: 2024-11-27	-

Convertible Notes Latest

2026-06-15

$500.0M

1 investor (Pro only)

Asset Sale 2024-11-27

$150.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Matthew B. Klein

CEO, PTC Therapeutics, Inc.

N

Neil Almstead

Chief Technical Operations Officer

J

John Baird, Ph.D.

Chief of Staff to the CEO

M

Mark E. Boulding

Executive Vice President and Chief Legal Officer

L

Lee Golden

Chief Medical Officer

P

Pierre Gravier

Chief Financial Officer

View 17 more team members with Pro

Unlock Full Team Directory

Recent News